Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · Real-Time Price · USD
0.179
-0.004 (-1.92%)
Mar 13, 2025, 3:53 PM EDT - Market open
Virpax Pharmaceuticals Employees
Virpax Pharmaceuticals had 7 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,723,889
Market Cap
4.74M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2022 | 7 | 0 | - |
| Dec 31, 2021 | 7 | 5 | 250.00% |
| Dec 31, 2020 | 2 | 0 | - |
| Dec 31, 2019 | 2 | - | - |
VRPX News
- 6 days ago - Virpax Looking to Use MET to Develop Intranasal COVID Vaccine - Business Wire
- 7 days ago - Virpax's NES100 to be Presented at The Society of Toxicology by NCATS - Business Wire
- 13 days ago - Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology - Business Wire
- 27 days ago - Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate - Benzinga
- 27 days ago - Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study - Business Wire
- 5 weeks ago - Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference - Business Wire
- 5 weeks ago - Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals' $6 Million Follow-On Offering - GlobeNewsWire
- 6 weeks ago - Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants - Business Wire